BioRestorative Therapies, Inc. (BRTX) Press Releases https://ir.biorestorative.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_f07b0c423e1f798e1a3146db853c2d2b/biorestorative/files/theme/images/logo-sm.png BioRestorative Therapies, Inc. Logo Equisolve Investor Relations Suite <![CDATA[BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform]]> https://ir.biorestorative.com/news-events/press-releases/detail/241/biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek-multi-channel-adoption-of-its-regenerative-biocosmeceutical-platform Tue, 21 Apr 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/241/biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek-multi-channel-adoption-of-its-regenerative-biocosmeceutical-platform <![CDATA[BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform]]> https://ir.biorestorative.com/news-events/press-releases/detail/240/biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform Tue, 07 Apr 26 08:15:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/240/biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform <![CDATA[BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease]]> https://ir.biorestorative.com/news-events/press-releases/detail/239/biorestorative-therapies-reports-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease Mon, 30 Mar 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/239/biorestorative-therapies-reports-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease <![CDATA[BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease]]> https://ir.biorestorative.com/news-events/press-releases/detail/238/biorestorative-therapies-to-present-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease Thu, 19 Mar 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/238/biorestorative-therapies-to-present-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease <![CDATA[BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026]]> https://ir.biorestorative.com/news-events/press-releases/detail/237/biorestorative-therapies-inc-to-participate-in-the-be-well-beauty-and-wellness-show-in-new-york-city-march-8-10-2026 Thu, 05 Mar 26 08:00:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/237/biorestorative-therapies-inc-to-participate-in-the-be-well-beauty-and-wellness-show-in-new-york-city-march-8-10-2026 <![CDATA[BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy]]> https://ir.biorestorative.com/news-events/press-releases/detail/236/biorestorative-therapies-inc-issues-letter-to-shareholders-highlighting-major-milestones-regulatory-alignment-clinical-execution-and-capital-strategy Wed, 04 Mar 26 08:00:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/236/biorestorative-therapies-inc-issues-letter-to-shareholders-highlighting-major-milestones-regulatory-alignment-clinical-execution-and-capital-strategy <![CDATA[BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs]]> https://ir.biorestorative.com/news-events/press-releases/detail/235/biorestorative-expands-global-protection-for-thermostem-a-potentially-longer-lasting-and-safer-cell-based-alternative-to-glp-1-drugs Tue, 24 Feb 26 08:30:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/235/biorestorative-expands-global-protection-for-thermostem-a-potentially-longer-lasting-and-safer-cell-based-alternative-to-glp-1-drugs <![CDATA[BioRestorative Announces Closing of $5.0 Million Public Offering]]> https://ir.biorestorative.com/news-events/press-releases/detail/234/biorestorative-announces-closing-of-5-0-million-public-offering Fri, 13 Feb 26 20:30:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/234/biorestorative-announces-closing-of-5-0-million-public-offering <![CDATA[BioRestorative Announces Pricing of $5.0 Million Public Offering]]> https://ir.biorestorative.com/news-events/press-releases/detail/233/biorestorative-announces-pricing-of-5-0-million-public-offering Wed, 11 Feb 26 22:30:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/233/biorestorative-announces-pricing-of-5-0-million-public-offering <![CDATA[BioRestorative Announces Positive Outcome from Type B Meeting with FDA]]> https://ir.biorestorative.com/news-events/press-releases/detail/232/biorestorative-announces-positive-outcome-from-type-b-meeting-with-fda Wed, 11 Feb 26 07:30:00 -0500 https://ir.biorestorative.com/news-events/press-releases/detail/232/biorestorative-announces-positive-outcome-from-type-b-meeting-with-fda